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Reduced cochlear blood flow (CBF) has been implicated in various pathologies of the inner ear, including sudden deafness, noise-induced 
hearing loss and Meniere's disease.. Thus the aim of some current therapeutic regimens to treat these conditions is to increase CBF and thereby 
improve oxygenation of the inner ear tissues. Most of the vasodilating agents in clinical use, however, do not have specific experimental evidence 
to support their effects on CBF. The hypotension which can follow systemic administration may limit their local effectiveness and general utility, 
just as it complicates the interpretation of the data in animal experiments. In the current study we investigated the effect of six agents, known for 
their systemic cardiovascular actions, on CBF: hydralazine, sodium nitroprusside, papaverine, nicotinic acid, verapamil and histamine. The effect 
of these drugs was studied after topical applications on the round window membrane (RWM) and systemic intravenous administrations. CBF was 
monitored with a laser Doppler flowmeter (LDF). Topical administration of sodium nitroprusside was the most effective in increasing CBF, 
followed, in order, by hydralazine and histamine. No change in CBF was observed for papaverine, verapamii or nicotinic acid. Systemic 
administrations of all the agents caused a marked decrease in blood pressure and variable effects on CBF. We discuss the CBF changes in 
relation to the different pharmacological mechanisms of action of each drug. The study demonstrates the effectiveness of topical application of 
vasodilating agents in increasing CBF. 
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Introduction 
Microcirculation plays an essential role in maintain- 
ing inner ear homeostasis. The cochlea's very intricate 
and extensive vascular system (Axelsson, 1971) sup- 
ports a tight coupling between cochlear function and 
oxygenation of the cochlear fluids (Lawrence et ai., 
1975; Brown et al., 1983). Moreover, it has been sug- 
gested that the vascular pathology of reduced inner ear 
blood flow may contribute to sudden deafness 
(Zajtchuk, 1979; Johnson et al., 1984), Meniere's dis- 
ease (Prazma, 1981), presbyacusis (Axelsson, 1971; 
Johnsson and Hawkins, 1972), hearing loss associated 
with hypercholesterolemia (Cummingham and Goet- 
zinger, 1974; Tami, 1985) and noise-induced hearing 
loss (Thorne and Nuttall, 1987). Treatments in use 
today are partly based on this assumption and attempt 
to increase the cochlear blood flow (Mattox, 1980; 
Hultcrantz, 1988; Nakatsu and Diamond, 1989). For 
the most part, experimental evidence supporting the 
effectiveness of these treatments for increasing CBF is 
lacking. Furthermore, the use of many drug treatments 
is complicated by cardiovascular side effects, such as 
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decreased blood pressure in response to systemically 
applied vasodilating drugs. 
The purpose of the current investigation was to 
examine the effects on the CBF of six agents which are 
known for their vasodilating effects. The pharmacologi- 
cal pathway of action of these drugs in producing 
vasodilation varies, and they were selected to examine 
the availability of each pathway in the control of CBF. 
This study evaluated their influence on CBF when 
administered both by intravenous (IV) injections and 
by topical application on the round window membrane 
(RWM). The comparison of the two routes of adminis- 
tration allows the assessment of the specific action of 
each drug in the cochlea, independent of its systemic 
effects. The dosages of the drugs were extrapolated 
from the human therapeutic range. Laser Doppler 
fiowmetry (LDF)was used for measuring tiic CBF. 
LDF has been shown to provide quantitative informa- 
tion about the dynamic changes of CBF (Miller et al., 
1983; Miller et al., 1984; Sillman et al., 1988; Miller 
and Dengerink, 1988). 
Methods 
Animals and preparation 
Ninety-five pigmented guinea pigs of either sex, 
weighing 240-500 g were used in these studies. All 
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subjects had a normal Preyer's reflex and were free of 
middle ear infection as assessed directly under the 
microscope. Anesthesia was induced by Nembutal (15 
mg/kg, IP initially, ,,,...wed by 7.5 mg/kg every two 
hours) and Innovar-Vet (0.4 ml/kg, IM initially, fol- 
lowed by 0.2 ml/kg every hour). Core body tempera- 
ture, measured with a rectal probe, was maintained at 
38 + I°C with a thermoregulated heating blanket. The 
animal head-holder, made of metal, was heated (by 
electrical heating elements) to skin temperature in 
order to prevent cooling of the cochlea. Tracheotomies 
were performed to ensure an adequate airway, and the 
subjects breathed spontaneously throughout the exper- 
iment. The right carotid artery was cannulated (poly- 
urethane catheter tubing, Micro-Renathane, Braintree 
Scientific) to monitor systemic blood pressure (BP)and 
the right external jugular vein was cannulated for intra- 
venous administration of drugs. The left bulla was 
exposed by a ventrolateral surgical approach and was 
carefully opened, preserving the function of the tym- 
panic membrane and ossicles in all preparations. Usin~ 
a cotton pledget, the mucosa and periosteum overlying 
the otic capsule were removed. 
CBF-recording 
A laser Doppler flowmeter (LDF) (Laser Flow, TSI 
Blood Perfusion Monitor 403) was used to monitor 
CBF. The LD probe was placed over the first or 
second cochlear turn. Petroleum gel was applied to the 
probe tip to provide efficient laser light coupling to the 
cochlea. All recordings were done under stable light 
illumination from the surgical microscope. The ratio of 
the change in CBF to the change in BP was also 
computed. This ratio, the normalized cochlear blood 
flow (nCBF) reflects flow changes in the cochlear circu- 
lation independent of the BP. A second LDF (Med 
Pacific, LD5000) was used to monitor skin blood flow 
(SBF) in some cases of each group. This skin probe was 
attached by tape to a shaved area of the abdomen. 
Experimental protocols 
Six agents, with different mechanisms for dilating 
vessels, were selected for this study. The drug-induced 
effects on CBF were examined after topical applica- 
tions to the RWM and after systemic administration. 
The topical approach was developed in a previous 
study (Ohls6n et al., 1991) which took advantage of the 
diffusability of low molecular weight (MW) drugs 
through the RWM (Tanaka and Motomura, 1981; Ry- 
back et al., 1984; Lundman et al., 1987; Morizono et 
al., 1989). The drugs selected for the current study had 
molecular weights below 500. Each of the six different 
drugs were also tested by IV administration. Regard- 
less of route of application, the experiment began by 
recording stable BP and CBF baselines for at least 15 
minutes before the test drug was administered. 
For topical application experiments, two concentra- 
tions of each drug were studied. The topical adminis- 
tration consisted of a visually controlled application of 
1-2/~l of the tested drug to the RWM where the drug 
was allowed to remain for up to 2 hours. The vehicle 
(physiological saline) was tested independently by 2/zl  
volume applications to the RWM. For systemic appli- 
cation experiments, IV administrations of two drug 
concentrations were measured and each was repeated 
when there was a fast and complete recovery from the 
drug effect; otherwise only a single drug application 
was tested for a given preparation. The systemic ad- 
ministrations were bolus injections (0.3-0.5 ml) given 
via the venous catheter. The CBF was measured for up 
to 2 hours following drug administrations. If a recovery 
occurred following the drug-induced change in CBF, a 
control administration of the vehicle alone (0.3-0.5 ml) 
was given before the next drug concentration. The 
animals were sacrificed by an IV overdose of Uthol. 
The drugs, their MW, concentrations and most widely 
accepted mode of action are given in Table I. 
All the animals tolerated the anesthesia and surgery 
well. Only animals with initial BP's above 40 mmHg 
were used in this study. 
Results 
Control administration of the drug vehicles resulted 
in no significant change of CBF, BP, or SBF. This was 
the case regardless of whether they were administered 
topically or systemically. Moreover no change in BP or 
SBF was observed following the topical applications of 
the drugs to the RWM, even when the agent caused 
significant changes in CBF. 
Topical administrations (N = 51) 
The overall results of the current work are summa- 
rized in Table II. One can see in column 2 of Table II 
that three of the tested agents caused a noticeable 
increase in CBF when administered topically. They 
were sodium nitroprusside, hydralazine, and histamine. 
Sodium nitroprusside clearly induced the greatest ef- 
fect. For the larger dose (3% solution) CBF more than 
doubled. Figure 1A shows the initial time course of 
change in CBF induced by the two concentrations of 
sodium nitroprusside from representative guinea pigs. 
Within 10 minutes following application of the drug, 
the laser Doppler flowmeter registered a maximum 
flux value. The larger CBF change (more than 100%) 
was induced by the higher sodium nitroprusside con- 
centration. There was no obvious recovery from these 
topically induced changes during the entire duration of 
the experiment (2 hours, although only 30 minutes is 
plotted in Fig. 1A). 
TABLE I 
SUMMARY OF APPLIED D R U G  CONCENTRATIONS, MOLECULAR WEIGHTS AND MODE OF ACTION 







I.V. m g / K g  
Molecular 
weight 
Mode of action 
1,3 2 ,4  1,4 4, 10 3 0,25 
0.0125-10 -3 0.25, 2 0.005 5, 10 0.1, 0.5, 1 0.1 
0.5.10 -3 
261.9 196.64 184.1 123.1 
guanylatecyclase guanylatecyclase receptors/second prostaglandins 
-cGMP -cGMP messengers -cAMP 
-cGMP? 
378.8 491.1 
phosphodiesterase Ca 2 +- 
inhibitors-cGMP channel 
-cAMP blocker 
The CBF changes caused by topically applied hy- 
dralazine were generally similar to those of sodium 
nitroprusside (Fig. 1B). However the maximum in- 
crease was significantly less (by approximately 50%) 
and some recovery following the peak change was 
apparent. The recovery occurred only during the first 
30 minutes following peak action and the level of 
recovery was small. CBF remained elevated by at least 
half of its induced maximum change. The onset time- 
course of CBF change was similar for the two drugs. 
As indicated in Table II, topical histamine demon- 
strated variable and weak effects on CBF. Two of the 4 
animals (in the high dose group) exhibited no CBF 
change following topically applied histamine, even when 
the application of the drug was repeated up to 4 times 
over a 1 hour period by removal and replacement of 
the 1-2 ml fluid volume on the RWM. The two ani- 
mals that did show a change produced a steady rise in 
CBF over 30 minutes and no subsequent recovery 
during the next 1.5 hours. 
No change in CBF was observed following topic 
administration of nicotinic acid, papaverine, or vera- 
pamil even with multiple applications to the round 
window ~embrane. 
Intravenous applications (N = 39) 
The one clear result indicated in Table II for the 
systemic administration of these vasodilators is the 
powerful influence they all have on BP (Table II). With 
the exception of the lower dose of nicotinic acid, BP 
TABLE !I 
SUMMARY OF DRUG EFFECTS ON COCHLEAR BLOOD FLOW AND SYSTEMIC BLOOD PRESSURE 
Topical Systemic 
Doses CBF BP SBF n Doses CBF BPF SBF n 
% % mg/kg  % % % change 
change change change 
Sodium 1 1' 82 [9.6] • • 4 0.0125 1' 10 [3.6] `[ 25 [8] T 15 [2.9] 3 
Nitroprusside 3 1' 116 [8.1] • • 4 0.5 1' 13 [5] [̀ 34 [2.4] 1' 15 [6.4] 3 
Hydralazine 2 T 36 [9.4] • • 8 0.25 • `[ 16 [1.4] • 4 
4 1`50 [11.2] • • 8 2 • `[44 [3.4] 1`20 # [11.6] 4 
Histamine 1 • • • 4 0.005 • ~ 7 • 3 
4 1`24 * [13.8] • • 4 0.05 1'25 [3] ~ 10 [2] • 3 
Nicotinic 4 • • • 6 5 • • • 3 
Acid 10 • • • 6 10 • ~ 10 1' 12 3 
Papaverine 3 • • • 4 0.1 1̀  10 `[ 10 4 
0.5 ~, 101`25 `[201`25 - 4 
1 ,[201`50 `[201`50 6 
Verapamil 0.25 • • • 3 0.1 • ~ 30 - 4 
o, no effect; - ,  not tested; *, 2 out of the 4 animals showed the e ~fect: # ,  3 out of the 4 
Columns giving % change: mean [one standard deviation]. 
T Increase; `[ Decrease. 
animals showed the effect. 
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Fig. 1. (A)  Influence of local sodium nitroprusside on CBF, at 1% 
( o )  and 3 %  (o).  Expressed as percent of initial baseline value. (B)  
Influence of local hydralazine on CBF, at 2 %  ( o )  and 4 %  (e).  
Expressed as percent of initial baseline value. 
reductions ranging to 44% were seen; and typically 
they were greater than 25%. These substantial reduc- 
tions were often accompanied by LD measured in- 
creases in blood flow in the skin and cochlea. More- 
over it is noteworthy that in some instances CBF and 
SBF showed no change even though systemic blood 
pressure was reduced. 
Figure 2 shows the BP, SBF and CBF changes 
induced by two concentrations of sodium nitroprusside 
given as bolus IV injections. This drug seems particu- 
larly interesting because its powerful vasodilative effect 
resulted in increase of both skin and cochlear blood 
flow even with large reductions in blood pressure. The 
alterations in BP and organ blood qow following IV 
administration generally showed partial or full recovery 
over 1 hour, while topical effects did not show recov- 
ery. However, there was no change in BP following 
topical administration. 
The effect of systemically administered histamine 
was similar to that observed following topical applica- 
tions of the drug, in that a slow change in CBF was 
induced over 30 minutes and only in some guinea pigs 
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Fig. 2. Effects of intravenous administered sodium nitroprusside at 
0.0125 ~ g / k g  (A) and 0.5 ~ g / k g  (B), on CBF (o ) ,  SBF (tx) and BP 
(O).  Expressed as percent of initial value. 
Papaverine was unique among the tested agents in 
demonstrating short term and recoverable effects. Fig- 
ure 3A shows an example of the changes in CBF and 
BP observed following bolus IV injection in one guinea 
pig. These results are typical in that papaverine consis- 
tently showed a faster effect on CBF than on BP. Thus, 
if the CBF is normalized for the change in BP, a 
distinct residual response is seen for all doses tested 
(Fig. 3B). For the higher dose, a highly significant 
transient change in vascular conductivity of the cochlea 
o c c u r s .  
It is worthy of note that no decrease in CBF oc- 
curred for any of the agents even though reductions in 
BP were evident for all drugs. 
Discussion 
Each of the orugs examined in this investigation is 
well known for its cardiovascular action in different 
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Fig. 3. ( A )  I n f l u e n c e  o f  i n t r a v e n o u s  in jec t ion  o f  1.0 m g / k g  p a p a v e r -  
ine on CBF (o) and on BP (o). Expressed as percentage change from 
initial baseline. (B) Change in ration of CBF to BP with different 
doses of intravenous injections of papaverine. 1 mg/mg (o), 0.5 
mg/mg ( z~ ), 0.1 mg//zg (El) 
the most part, they are anti-hypertensive agents or are 
in use for the treatment of angina pectoris. The influ- 
ence of these agents on CBF, observed in this investi- 
gation, provides some indication of various pharmaco- 
logical mechanisms available to the inner ear for con- 
trolling CBF. The fundamental mechanisms underlying 
drug induced vascular smooth muscle relaxation is un- 
known in many tissues. However, various generic 
mechanisms have been described and intensively stud- 
ied. Basically, the drugs examined in this investigation 
have two principal modes of action both finally leading 
to dephosphorylation of myosin and inducing vascular 
relaxation (Greenberg et al., 1983; Goodman and 
Gilman, 1985; Wa!dman and Murad, 1987). A vasodila- 
tor may directly antagonize intracellular mechanisms 
responsible for the accumulation of free cytosolic cal- 
cium and /o r  it may initiate cascade reactions via cAMP 
and/or  cGMP pathways. The drug can also block 
extracellular influx of calcium or activate different sec- 
ond messenger pathways via receptor binding that in 
turn block influx. Table I summarizes, in the bottom 
row, the perceived mode of action of the vasodilating 
agents used. 
(1) Sodium nitroprusside and hydralazine stimulate the 
activity of guanylate cyclase, via the mediator nitrous 
oxide, resulting in elevation of intracellular cGMP. 
cGMP in the presence of C a  2 + leads to a dephosphory~ 
lation of myosin. 
(2) The vasodilating action of histamine is complex. In 
part it may activate H1 and H2 receptors on vascular 
smooth muscle and on the endothelium. Activation of 
the receptors initiates a complex secondary pathway 
involving cGMP, cAMP and the prostaglandins result- 
ing in myosin dephosphorylation. Inhibition of nore- 
pinephrine release has also been proposed as a possi- 
ble mechanism for the vasodilatory action of histamine, 
as well as changes in vascular permeability (Greenberg 
et al., 1983; Woodward and Ledgard, 1986) and ele- 
vated levels of cGMP have also been associated with 
the action of histamine (Greenberg et al., 1983; Good- 
man and Gilman, 1985). 
(3) Nicotinic acid induces vasodilation by elevating 
endothelial prostaglandins, which activate adenylate 
cyclase and possibly also guanylate cyclase (Goodman 
and Gilman, 1985) again leading to p-myosin dephos- 
phorylation. 
(4) Papaverine induces a rise in cAMP and/or  cGMP 
via inhibition of phosphodiesterases, which are respon- 
sible for the breakdown of the cyclic nucleotides 
(Greenberg et al., 1983). 
(5) Verapamil is a calcium channel antagonist, blocking 
the movement of extracellular calcium into smooth 
muscle cells, thereby restricting myofibril contractions 
which require the binding of calcium to contractable 
proteins. (Greenberg et al., 1983; Goodman and 
Gilman, 1985). 
The RWM acts as a physical barrier to the inner 
ear. There is, however, evidence that active transport 
mechanisms exist within the membrane for the passage 
of large molecular weight proteins (Tanaka and Moto- 
mura, 1981; Lundman and Holmquist, 1987). Passive 
diffusion of smaller molecules up to MW 500 has also 
been demonstrated (Ito, 1991). The drugs chosen for 
this study had a MW between 123 and 491. However it 
is of interest that the two agents without effect after 
topical application, verapamil and papaverine, had 
higher MWs than the more effective drugs (Table I), 
indicating that their diffusion across the RWM may 
have been impeded. To evaluate this, some experi- 
ments with papaverine were conducted where the 
RWM was punctured to allow free mixing of drug with 
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perilymph. In these experiments no effect on CBF was 
recorded. 
In this study topically applied sodium nitroprusside 
and hydralazine were the most powerful vasodilating 
agents tested. They induced a dose-dependent re- 
sponse with no change in BP or SBF (Table II). These 
agents affect vascular smooth muscle by activation of 
the enzyme guanylate-cyclase. Nitroprusside and hy- 
dralazine release nitric oxide (NO) which has recently 
been identified as an endothelium-derived relaxing fac- 
tor (Ignarro, 1989). NO is a very potent dilator, stimu- 
lating the production of cGMP via guanylate cyclase 
(Ignarro, 1989) (Table I). Sodium nitroprusside, which 
causes a larger effect on CBF than hydralazine, acts on 
the smooth muscle of both arterioles and venules, 
while hydralazine is a pure arteriolar dilator (Good- 
man and Gilman, 1985; Shepherd and Irvine, 1986). 
The findings of this study are consistent with the 
relative effectiveness of these agents described in other 
investigations (Nelson and Suresh, 1988). Sodium ni- 
troprusside was the only drug which significantly in- 
creased CBF when administered intravenously. This 
effect was an approximately 10% increase in CBF; an 
effect of some significance given the 35% decrease in 
systemic BP. 
The data are also partly consistent with the results 
reported for hydralazine by Snow and Suga (1973). In 
that study, systemically applied hydralazine increased 
cochlear blood flow (measured by impedance phlethys- 
mography) and simultaneously decreased systemic 
blood pressure. Thus the normalized cochlear blood 
flow increased, as it did in the current work. The 
difference between the two studies regarding the abso- 
lute CBF for systemically administered hydralazine 
could be related to measurement methodology. Prazma 
et al. (1981) point out the potential shortcomings of 
impedance phlethysmography. Laser Doppler flowme- 
try, of course, is subject to different questions of inter- 
pretation (Nuttall, 1988). 
Both topical and IV histamine caused an increase in 
CBF. When administered IV this was accompanied by 
a decrease in BP. The topical effect of histamine on 
CBF was not a consistent finding, being observed in 
only half of the animal tests. However, the positive 
result may be interpreted as evidence supporting local 
histamine receptors in the vasculature of the guinea 
pig cochlea. Given current knowledge of histamine 
receptors and the physiology of their action in different 
organs (Goodman and Gilman, 1985), it is impossible 
to state whether the effect seen in the cochlea was 
mediated via a H2 or both H1 and H2 receptor/s. 
Nicotinic acid did not affect CBF. This is consistent 
with observations made on brain blood flow and in 
previous study on CBF. Hultcrantz et a1.(1982) found 
no effect on CBF when nicotinic acid was administered 
IV in intact animals. However, when nicotinic acid was 
given to animals during electrical stimulation of the 
cervical sympathetic chain, an increase of the reduced 
CBF by 25% was registered. In the present study 
nicotinic acid increased only SBF. The vasodilation in 
the skin may be mediated through release of 
prostaglandins (PG) as it is inhibited by aspirin (Good- 
man and Gilman, 1985). Since PGs are synthesized in 
the inner ear (Escoubet et al., 1985), the lack of effect 
of nicotinic acid on CBF suggests that something more 
is necessary to activate the vasodilative mechanism. 
Further experiments including sympathetic stimulation 
would help to clarify this question. 
Topically applied papaverine was ineffective in in- 
creasing the CBF, but when given IV in the highest 
dose tested, it was found to increase CBF more than it 
changed the BP. The increased nCBF suggests a tran- 
sient additional local dilating effect of papaverine on 
the cochlear vasculature. These transient increases in 
CBF appear consistent with the findings of Snow and 
Suga (1973) and Prazma et al. (1988) for papvarin and 
ethaverin, respectively, who show increased CBF and 
decreased systemic blood pressure during systemic ad- 
ministrations. 
Topical application of verapamil failed to induce 
changes in CBF or BP. However, following IV adminis- 
tration a marked decline in BP was observed with the 
CBF falling less. This may indicate a small effect of 
verapamil on cochlear vasculature smooth muscle but 
in the absence of a topical effect it may also be 
interpreted as evidence to support local autoregula- 
tion. 
From a clinical viewpoint, a significant finding of 
this study was that systemic administration of potent 
vasodilating agents resulted in little or no net increase 
in the CBF. Moreover, the resultant hypotensive ef- 
fects in the guinea pig model put into question their 
use in the treatment of suspected inner ear ischemia. 
The cochlear blood circulation is anatomically closely 
related to the much larger intracerebral circulation. By 
implication it may be subject to autoregulatory mecha- 
nisms to provide constant blood flow over a wide range 
of perfusion pressures. A distinct autoregulatory sys- 
tem within the cochlea could act separately (Hultcrantz 
et al., 1977; Miller and Dengerink, 1988) from the 
cerebral circulation. On the other hand, local adminis- 
tration of vasodilator drugs to the cochlear microcircu- 
lation via the RWM can result in selective improve- 
ments of CBF with no effect on BP. The marked 
elevations of CBF following administration of nitro- 
prusside and hydralazine is evidence of this. The dura- 
tion of this blood flow response is prolonged, in the 
case of nitroprusside, over 2 hours. This is in contrast 
to the known transient action of nitroprusside when 
administered systemically in man (Goodman and 
Gilman, 1985). The reason for this prolonged effect is 
not known at this time, but could be related to the 
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effective dose reaching the smooth muscle of cochlear 
vessels or to slow clearance of the drug from cochlear 
fluids. 
We believe that the model developed for this study, 
i.e., the local application of drugs directly to the 
cochlea, is a valid and useful one to assess their cochlear 
vascular activity. As usual, caution must be exercised in 
the interpretation of these results, for unanesthetized 
animals not subjected to surgical trauma. Furthermore, 
there is the important question of whether increased 
blood flow is of any benefit for the cochlear function. 
Further studies assessing stability or changes in 
cochlear physiology associated with these drugs, are 
required to provide an adequate rationale to support 
this strategy of treatment for clinical use in man. 
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